Genotyping Assay Market

Genotyping Assay Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023

Report Code: BT 3397 Nov, 2018, by marketsandmarkets.com

[280 Pages Report] The global genotyping market is projected to reach USD 31.9 billion by 2023 from USD 11.8 billion in 2018, at a CAGR of 22.0%. This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Genotyping Assay Market

Secondary Research

Secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the genotyping market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors of companies manufacturing apoptosis assay products, key opinion leaders, and suppliers and distributors, whereas, the industry experts from the demand side include pharmaceutical R&D directors, researchers, biotechnologists, and related key personnel.

A breakdown of the primary respondents is provided below:

Genotyping Assay Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product, application, technology, end user, and region).

Data Triangulation

After arriving at the market size, the total genotyping market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, and forecast the genotyping market, by product, technology, application, end user, and region
  • To provide detailed information regarding factors influencing market growth (such as drivers, restraints, opportunities, challenges, and industry trends)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies
  • To strategically analyze different geographical regions such as North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments such as mergers and acquisitions, product developments and approvals, agreements, collaborations, partnerships, expansions, and funding activities in the genotyping market

Scope of the Report:

Report Metric

Details

Market size available for years

2016–2023

Base year considered

2017

Forecast period

2018–2023

Forecast units

Value (USD)

Segments covered

Application segments in industries such as pharmacogenomics, diagnostics & personalized medicine, agricultural biotechnology, animal genetics, and other applications

Geographies covered

North America, Europe, APAC, Latin America, Middle East, and Africa.

Companies covered

Thermo Fisher Scientific (US), Illumina (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).

The research report categorizes the market into the following segments and subsegments:

Genotyping Market, By Product

  • Reagents & Kits
  • Genotyping Services
  • Instruments
    • Sequencers & Amplifiers
    • Analyzers
  • Bioinformatics
    • Software
    • Services

Genotyping Market, By Technology

  • PCR
    • Real-time PCR
    • Digital PCR
  • Microarrays
  • Sequencing
    • NGS
    • Pyrosequencing
    • Sanger Sequencing
  • Capillary Electrophoresis
    • Amplified Fragment Length Polymorphism
    • Restricted Fragment Length Polymorphism
    • Single-stranded Conformation Polymorphism
  • MALDI-TOF
  • Other Technologies (Allele-specific Oligonucleotide (ASO) Probes and Fluorescence In Situ Hybridization (FISH))

Genotyping Market, By Application

  • Pharmacogenomics
  • Diagnostic & Personalized Medicine
  • Agricultural Biotechnology
  • Animal Genetics
  • Other Applications (Prenatal Testing, Human Forensics, Microbial Genomic Studies, and Aquaculture Breeding Studies)

Genotyping Market, By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Diagnostic and Research Laboratories
  • Academic Institutes
  • Other End Users (Animal and Aqua Genetics Companies, Greenhouses, and Farms)

Genotyping Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific genotyping market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Latin American genotyping market into Brazil, Mexico, and others.

The global genotyping market is projected to reach USD 31.9 billion by 2023 from USD 11.8 billion in 2018, at a CAGR of 22.0%. The growth of this market is mainly driven by technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases.

The PCR segment is expected to account for the largest share of the genotyping market in 2018

On the basis of technology, the PCR segment is expected to account for the largest share of the market in 2018. The large share of this market segment can be attributed to the emergence of new technologies such as real-time PCR, reverse transcriptase PCR, nested PCR, hot-start PCR, allele-specific PCR, and multiplex PCR. In addition, technological advancements in PCR instruments and reagents and the increasing application of PCR technologies in the fields of personalized medicine, genetics, prenatal testing, life science research, and forensics; the growing adoption of PCR among researchers and healthcare professionals; and increased funding, grants, and public-private investments for PCR-based research are contributing to market growth.

The reagents & kits segment is expected to grow at the highest CAGR during the forecast period

Based on product, the reagents and kits are expected to grow at the highest rate during the forecast period. This segment is expected to witness the highest CAGR due to the easy accessibility of a wide range of reagents and the increasing need for genotyping in various applications.

Genotyping Assay Market

The APAC region is expected to grow at the highest CAGR during the forecast period

The genotyping market in the APAC is expected to grow at the highest CAGR during the forecast period. This is due to the increasing incidence of chronic diseases, and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases and the spread of infectious and microbial diseases in APAC countries. Global pharmaceutical and biopharmaceutical companies are also increasingly outsourcing clinical research and trials to companies in this region, which has increased the demand for genotyping products for drug profile assessment, drug efficacy and safety assessment, dosing determination, and drug response evaluation.

The prominent players in the global genotyping market are Thermo Fisher Scientific (US), Illumina (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).

Illumina

Illumina is a leading NGS products and services provider in the genotyping market. The company offers a technologically advanced and innovative product portfolio. The company uses microfluidic technology to provide NGS services. It has a wide geographic presence with direct distribution channels in around 35 countries and manufacturing & R&D facilities in North America, Latin America, Europe, and the Asia Pacific. This allows the company to reach out to a large customer base.

The company also invests a significant amount of its revenue on R&D to enhance its offerings and sustain its position in the market. In 2017, the company invested 19.8% of its revenue on R&D. The company also focuses on strategic agreements with leading players in the market to co-develop advanced technologies and strengthen its research and commercialization capabilities.

Thermo Fisher Scientific

Thermo Fisher Scientific provides superior quality genotyping and gene expression products, analytical instruments, laboratory equipment, software, services, consumables, and reagents. The company continuously increases its capabilities in technologies and software & services and leverages its extensive global channels to address customers’ emerging needs. To further strengthen its position in the market, the company strategically invests in acquisitions and product innovations.

Over the years, the company has maintained its leading position in the market through continuous innovation and product development. In this regard, in June 2018, the company launched the Ion AmpliSeq HD technology in NGS. The company’s wide product offerings along with a strong geographical network helped it to maintain its leading position in the market.

Recent Developments

  • In 2018, Danaher Corporation acquired Integrated DNA Technologies Inc. (US). This acquisition strengthened Danaher’s Life Sciences platform. IDT will operate as a standalone operating company and brand within Danaher Corporation.
  • In 2018, Thermo Fisher Scientific signed a partnership with Illumina (US) that enabled Illumina to sell the Ion AmpliSeq technology to researchers who conduct scientific studies using Illumina’s next-generation sequencing (NGS) platforms.
  • In 2018, Illumina launched the iSeq 100 Sequencing System.
  • In 2018, Agilent technologies opened a new logistics center in Texas to increase its capacity for house inventory and to fulfill the growing demand for NGS products from its genomics group.

Critical questions the report answers:

  • Where will all these developments take the industry in the medium to long-term?
  • What are the major end users of genotyping applications?
  • What are the application areas of the genotyping?
  • Which are the major genotyping products?
  • Which technologies are mainly used for the genotyping?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 22)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Market Segmentation, By Region
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 26)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 36)

4 Premium Insights (Page No. - 44)
    4.1 Genotyping Market Overview
    4.2 Asia Pacific: Genotyping Market, By Product & Service, By Country, 2017
    4.3 Geographic Snapshot of the Genotyping Market
    4.4 Geographic Mix: Genotyping Market
    4.5 Genotyping Market: Developing vs Developed Markets

5 Market Overview (Page No. - 48)
    5.1 Introduction
    5.2 Market Dynamics: Impact Analysis
    5.3 Market Drivers
           5.3.1 Technological Advancements and Decreasing Prices of Dna Sequencing
           5.3.2 Increasing Incidence of Genetic Diseases and Rising Awareness on Personalized Medicine
           5.3.3 Growing Importance of Genotyping in Drug Development
           5.3.4 Increasing Demand for Bioinformatics Solutions in Data Analysis
    5.4 Market Restraints
           5.4.1 High Cost of Equipment Used in Genotyping
    5.5 Market Opportunities
           5.5.1 Growing Importance of Sequencing Projects
           5.5.2 Increasing Application Areas of Genotyping
           5.5.3 Increasing Demand for Genome Analysis in Plant and Animal Livestock
    5.6 Market Challenges
           5.6.1 Data Management in Genotyping Research
           5.6.2 Dearth of Trained Resources

6 Industry Insights (Page No. - 55)
    6.1 Industry Trends
           6.1.1 Increasing Demand for Genotyping & Sequencing Services
           6.1.2 Increasing Collaborations
           6.1.3 Increasing Awareness
    6.2 Regulatory Analysis
           6.2.1 Us
           6.2.2 Europe
           6.2.3 Japan
           6.2.4 China
           6.2.5 India
    6.3 Strategic Benchmarking
           6.3.1 Genotyping Market: Product Portfolio Analysis (Instruments & Kits)
           6.3.2 Genotyping Market: Product Portfolio Analysis (Bioinformatics)

7 Genotyping Market, By Product & Service (Page No. - 63)
    7.1 Introduction
    7.2 Reagents & Kits
           7.2.1 Reagents & Kits Accounted for the Largest Share of the Genotyping Market in 2017
    7.3 Genotyping Services
           7.3.1 Increasing Demand for Sequencing and Genotyping Services From Hospitals, Small- and Medium-Sized Research Centers, and Pharmaceutical Companies to Drive the Growth of This Segment
    7.4 Instruments
           7.4.1 Sequencers & Amplifiers
                    7.4.1.1 Sequencers & Amplifiers Segment to Register the Highest Growth Rate in the Genotyping Instruments Market During the Forecast Period
           7.4.2 Analyzers
                    7.4.2.1 Growing Automation and Advancements in Analyzers With High-Throughput Capacities are the Major Factors Driving Market Growth
    7.5 Bioinformatics
           7.5.1 Software
                    7.5.1.1 Software Segment Accounted for the Largest Share of the Genotyping Bioinformatics Market in 2017
           7.5.2 Services
                    7.5.2.1 Shortage of Skilled Bioinformatics Professionals and the Growing Applications of Bioinformatics in Various Industries are the Major Factors Driving the Growth of This Segment

8 Genotyping Market, By Technology (Page No. - 76)
    8.1 Introduction
    8.2 Polymerase Chain Reaction
           8.2.1 Real-Time PCR
                    8.2.1.1 Real-Time PCR Dominated the PCR Market in 2017, Primarily Due to the Growing Adoption of These Instruments Among Researchers and Healthcare Professionals
           8.2.2 Digital PCR
                    8.2.2.1 The High Cost of Dpcr Instruments to Restrain the Growth of This Market
    8.3 Microarrays
           8.3.1 Increasing Demand for Personalized Medicine and Continuous Launch of Custom Arrays By Leading Players to Drive Market Growth
    8.4 Sequencing
           8.4.1 Next-Generation Sequencing
                    8.4.1.1 NGS to Witness the Highest Growth Rate in the Sequencing Market During the Forecast Period
           8.4.2 Pyrosequencing
                    8.4.2.1 Growing Demand for Pyrosequencing By Pharmaceutical and Biotechnology Companies to Drive the Adoption of This Technology Segment
           8.4.3 Sanger Sequencing
                    8.4.3.1 Increasing Use of This Technology in Small-Scale Experiments is the Major Factor Driving Market Growth
    8.5 Capillary Electrophoresis
           8.5.1 Amplified Fragment Length Polymorphism
                    8.5.1.1 Aflp Technique to Witness the Highest Growth Rate in the Capillary Electrophoresis Market During the Forecast Period
           8.5.2 Restriction Fragment Length Polymorphism
                    8.5.2.1 Increasing Demand for Rflp From Forensics, Agricultural Institutions, and Pharmaceutical and Biotechnology Companies–Major Factor Driving Market Growth
           8.5.3 Single-Strand Conformation Polymorphism
                    8.5.3.1 Increasing Applications of Sscp in Virology are Expected to Play A Key Role in the Growth of the Sscp Market
    8.6 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry
           8.6.1 Increasing Applications of This Technique in Clinical Diagnostics and Pharmacogenomics to Drive Market Growth
    8.7 Other Technologies

9 Genotyping Market, By Application (Page No. - 106)
    9.1 Introduction
    9.2 Pharmacogenomics
           9.2.1 Pharmacogenomics Segment Accounted for the Largest Share of the Genotyping Market in 2017
    9.3 Diagnostics & Personalized Medicine
           9.3.1 Technological Advancements and Increasing Potential of Developing Diagnostics Tests Through Rapid Genotyping Techniques are the Key Factors Driving the Growth of This Application Segment
    9.4 Animal Genetics
           9.4.1 Lower Adoption of Genotyping Technologies in Animal Breeding Programs in Developing Countries to Restrain the Growth of This Segment
    9.5 Agricultural Biotechnology
           9.5.1 Increasing Number of Research Laboratories and Greenhouses Using Plant Genotyping and Continuous Product Innovations and New Product Launches are Driving the Growth of the Agricultural Biotechnology Segment
    9.6 Other Applications

10 Genotyping Market, By End User (Page No. - 116)
     10.1 Introduction
     10.2 Pharmaceutical & Biopharmaceutical Companies
             10.2.1 Pharmaceutical & Biopharmaceutical Companies to Register the Highest Growth During the Forecast Period
     10.3 Diagnostic & Research Laboratories
             10.3.1 Growing Preference for Personalized Medicine and Increasing Research Focused on Personalized Diagnosis are the Key Factors Driving Market Growth
     10.4 Academic Institutes
             10.4.1 Increasing Research Activities for Drug Discovery and Rising Industry-Academia Collaborations for Drug Development are the Key Factors Driving Market Growth
     10.5 Other End Users

11 Genotyping Market, By Region (Page No. - 124)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                        11.2.1.1 US Dominated the North American Genotyping Market in 2018; This Trend to Continue During the Forecast Period
             11.2.2 Canada
                        11.2.2.1 Increasing Incidence of Genetic Diseases & the Availability of A Wide Range of Genotyping Products to Drive Market Growth in Canada
     11.3 Europe
             11.3.1 Germany
                        11.3.1.1 Germany Accounted for the Largest Share of the European Genotyping Market in 2017
             11.3.2 France
                        11.3.2.1 Increasing Incidence of Genetic Disorders & Growing Public-Private Investments are Driving the Growth of the Genotyping Market in France
             11.3.3 UK
                        11.3.3.1 UK to Witness the Highest Growth in the European Genotyping Market During the Forecast Period
             11.3.4 Italy
                        11.3.4.1 Presence of A Well-Developed Healthcare System and Rapid Growth in the Geriatric Population are Key Factors Driving Market Growth in Italy
             11.3.5 Spain
                        11.3.5.1 The Lingering Effect of Economic Downturns Will Continue to Affect Healthcare in Spain
             11.3.6 Rest of Europe
     11.4 Asia Pacific
             11.4.1 China
                        11.4.1.1 Infrastructural Improvements in China’s Healthcare System Have Boosted Treatment Rates and Care Delivery
             11.4.2 Japan
                        11.4.2.1 Strong Base of Pharmaceutical Activity Will Contribute to the Use of Genotyping
             11.4.3 India
                        11.4.3.1 Growth of the Pharmaceutical Industry has Highlighted the Need for Better Infrastructure in India
             11.4.4 Rest of APAC
     11.5 Latin America
     11.6 Middle East and Africa

12 Competitive Landscape (Page No. - 195)
     12.1 Overview
     12.2 Product Portfolio Matrix
     12.3 Market Share Analysis
     12.4 Competitive Situations and Trends
             12.4.1 Agreements, Collaborations, and Partnerships
             12.4.2 Acquisitions
             12.4.3 Expansions

13 Company Profiles (Page No. - 204)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     13.1 Illumina, Inc.
     13.2 Thermo Fisher Scientific, Inc.
     13.3 Roche Diagnostics Limited
     13.4 Qiagen N.V.
     13.5 Danaher Corporation
     13.6 Agilent Technologies, Inc.
     13.7 Fluidigm Corporation
     13.8 GE Healthcare
     13.9 Genewiz, Inc.
     13.10 Integrated Dna Technologies, Inc. (A Subsidiary of Danaher Corporation)
     13.11 Perkinelmer, Inc.
     13.12 Bio-Rad Laboratories, Inc.
     13.13 Eurofins Scientific
     13.14 Pacific Biosciences of California, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 271)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Available Customizations
     14.5 Related Report
     14.6 Author Details


List of Tables (219 Tables)

Table 1 Standard Currency Conversion Rates
Table 2 Genotyping Market Snapshot, 2018 vs 2023
Table 3 Comparative Data: Older vs Latest Platforms, By Company
Table 4 Recent Developments in the Genotyping Market
Table 5 China: Time, Cost, and Complexity of Registration Process
Table 6 Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 7 Genotyping Reagents & Kits Market, By Country, 2016–2023 (USD Million)
Table 8 Genotyping Services Market, By Country, 2016–2023 (USD Million)
Table 9 Genotyping Instruments Market, By Type, 2016-2023 (USD Million)
Table 10 Genotyping Instruments Market, By Country, 2016–2023 (USD Million)
Table 11 Genotyping Sequencers & Amplifiers Market, By Country, 2016–2023 (USD Million)
Table 12 Genotyping Analyzers Market, By Country, 2016–2023 ( USD Million)
Table 13 Genotyping Bioinformatics Market, By Type, 2016-2023, (USD Million)
Table 14 Genotyping Bioinformatics Market, By Country, 2016–2023 (USD Million)
Table 15 Genotyping Bioinformatics Software Market, By Country, 2016–2023 (USD Million)
Table 16 Genotyping Bioinformatics Services Market, By Country, 2016–2023 (USD Million)
Table 17 Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 18 Comparative Study: Real-Time PCR vs Digital PCR
Table 19 Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 20 Polymerase Chain Reaction Market, By Country, 2016–2023 (USD Million)
Table 21 Major Real-Time PCR Products Available in the Market
Table 22 Real-Time PCR Market, By Country, 2016–2023 (USD Million)
Table 23 Major Digital PCR Products Available in the Market
Table 24 Digital PCR Market, By Country, 2016–2023 (USD Million)
Table 25 Major Microarray Products Available in the Market
Table 26 Microarrays Market, By Country, 2016–2023 (USD Million)
Table 27 Sequencing Market, By Type, 2016–2023 (USD Million)
Table 28 Sequencing Market, By Country, 2016–2023 (USD Million)
Table 29 Major Next-Generation Sequencing Products Available in the Market
Table 30 Next-Generation Sequencing Market, By Country, 2016–2023 (USD Million)
Table 31 Major Pyrosequencing Products Available in the Market
Table 32 Pyrosequencing Market, By Country, 2016–2023 (USD Million)
Table 33 Major Sanger Sequencing Products Available in the Market
Table 34 Sanger Sequencing Market, By Country, 2016–2023 (USD Million)
Table 35 Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 36 Capillary Electrophoresis Market, By Country, 2016–2023 (USD Million)
Table 37 Major Aflp Products Available in the Market
Table 38 Amplified Fragment Length Polymorphism Market, By Country, 2016–2023 (USD Million)
Table 39 Major Rflp Products Available in the Market
Table 40 Restriction Fragment Length Polymorphism Market, By Country, 2016–2023 (USD Million)
Table 41 Major Sscp Products Available in the Market
Table 42 Single-Strand Conformation Polymorphism Market, By Country, 2016–2023 (USD Million)
Table 43 Major Maldi-Tof Products Available in the Market
Table 44 Maldi-Tof Mass Spectrometry Market, By Country, 2016–2023 (USD Million)
Table 45 Major Products Available in the Market
Table 46 Genotyping Market for Other Technologies, By Country, 2016–2023 (USD Million)
Table 47 Genotyping Market, By Application, 2016–2023 (USD Million)
Table 48 Genotyping Market for Pharmacogenomics, By Country, 2016–2023 (USD Million)
Table 49 Genotyping Market for Diagnostics & Personalized Medicine, By Country, 2016–2023 (USD Million)
Table 50 Genotyping Market for Animal Genetics, By Country, 2016–2023 (USD Million)
Table 51 Genotyping Market for Agricultural Biotechnology, By Country, 2016–2023 (USD Million)
Table 52 Genotyping Market for Other Applications, By Country, 2016–2023 (USD Million)
Table 53 Genotyping Market, By End User, 2016–2023 (USD Million)
Table 54 Genotyping Market for Pharmaceutical & Biopharmaceutical Companies, By Country, 2016–2023 (USD Million)
Table 55 Genotyping Market for Diagnostic and Research Laboratories, By Country, 2016–2023 (USD Million)
Table 56 Genotyping Market for Academic Institutes, By Country, 2016–2023 (USD Million)
Table 57 Genotyping Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 58 Genotyping Market, By Region, 2016–2023 (USD Million)
Table 59 North America: Genotyping Market, By Country, 2016–2023 (USD Million)
Table 60 North America: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 61 North America: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 62 North America: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 63 North America: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 64 North America: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 65 North America: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 66 North America: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 67 North America: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 68 North America: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 69 US: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 70 US: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 71 US: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 72 US: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 73 US: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 74 US: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 75 US: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 76 US: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 77 US: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 78 Canada: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 79 Canada: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 80 Canada: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 81 Canada: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 82 Canada: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 83 Canada: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 84 Canada: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 85 Canada: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 86 Canada: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 87 Europe: Genotyping Market, By Country, 2016–2023 (USD Million)
Table 88 Europe: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 89 Europe: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 90 Europe: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 91 Europe: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 92 Europe: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 93 Europe: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 94 Europe: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 95 Europe: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 96 Europe: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 97 Germany: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 98 Germany: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 99 Germany: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 100 Germany: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 101 Germany: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 102 Germany: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 103 Germany: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 104 Germany: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 105 Germany: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 106 France: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 107 France: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 108 France: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 109 France: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 110 France: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 111 France: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 112 France: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 113 France: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 114 France: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 115 UK: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 116 UK: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 117 UK: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 118 UK: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 119 UK: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 120 UK: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 121 UK: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 122 UK: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 123 UK: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 124 Italy: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 125 Italy: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 126 Italy: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 127 Italy: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 128 Italy: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 129 Italy: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 130 Italy: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 131 Italy: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 132 Italy: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 133 Spain: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 134 Spain: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 135 Spain: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 136 Spain: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 137 Spain: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 138 Spain: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 139 Spain: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 140 Spain: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 141 Spain: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 142 RoE: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 143 RoE: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 144 RoE: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 145 RoE: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 146 RoE: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 147 RoE: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 148 RoE: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 149 RoE: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 150 RoE: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 151 APAC: Genotyping Market, By Country, 2016–2023 (USD Million)
Table 152 APAC: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 153 APAC: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 154 APAC: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 155 APAC: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 156 APAC: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 157 APAC: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 158 APAC: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 159 APAC: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 160 APAC: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 161 China: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 162 China: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 163 China: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 164 China: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 165 China: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 166 China: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 167 China: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 168 China: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 169 China: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 170 Japan: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 171 Japan: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 172 Japan: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 173 Japan: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 174 Japan: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 175 Japan: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 176 Japan: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 177 Japan: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 178 Japan: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 179 India: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 180 India: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 181 India: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 182 India: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 183 India: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 184 India: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 185 India: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 186 India: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 187 India: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 188 RoAPAC: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 189 RoAPAC: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 190 RoAPAC: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 191 RoAPAC: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 192 RoAPAC: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 193 RoAPAC: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 194 RoAPAC: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 195 RoAPAC: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 196 RoAPAC: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 197 Latin America: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 198 Latin America: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 199 Latin America: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 200 Latin America: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 201 Latin America: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 202 Latin America: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 203 Latin America: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 204 Latin America: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 205 Latin America: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 206 MEA: Genotyping Market, By Product & Service, 2016–2023 (USD Million)
Table 207 MEA: Genotyping Instruments Market, By Type, 2016–2023 (USD Million)
Table 208 MEA: Genotyping Bioinformatics Market, By Type, 2016–2023 (USD Million)
Table 209 MEA: Genotyping Market, By Technology, 2016–2023 (USD Million)
Table 210 MEA: Polymerase Chain Reaction Market, By Type, 2016–2023 (USD Million)
Table 211 MEA: Sequencing Market, By Type, 2016–2023 (USD Million)
Table 212 MEA: Capillary Electrophoresis Market, By Type, 2016–2023 (USD Million)
Table 213 MEA: Genotyping Market, By Application, 2016–2023 (USD Million)
Table 214 MEA: Genotyping Market, By End User, 2016–2023 (USD Million)
Table 215 Growth Strategy Matrix (2015–2018)
Table 216 Product Launches, Approvals, and Enhancements, 2015–2018
Table 217 Collaborations, Partnerships, and Agreements, 2015–2018
Table 218 Acquisitions, 2015–2018
Table 219 Expansions, 2015–2018


List of Figures (53 Figures)

Figure 1 Research Design
Figure 2 Primary Sources
Figure 3 Breakdown of Primary Interviews (Supply Side): By Company Type, Designation, and Region
Figure 4 Breakdown of Primary Interviews (Demand Side): By End User and Region
Figure 5 Data Triangulation Methodology
Figure 6 Genotyping Market, By Product & Service, 2018 vs 2023 (USD Million)
Figure 7 Genotyping Instruments Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Bioinformatics Market, By Type, 2018 vs 2023 (USD Million)
Figure 9 Genotyping Market, By Technology, 2018 vs 2023 (USD Million)
Figure 10 PCR Market, By Type, 2018 vs 2023 (USD Million)
Figure 11 Sequencing Market, By Type, 2018 vs 2023 (USD Million)
Figure 12 Capillary Electrophoresis Market, By Type, 2018 vs 2023 (USD Million)
Figure 13 Genotyping Market, By Application, 2018 vs 2023 (USD Million)
Figure 14 Genotyping Market, By End User, 2018 vs 2023 (USD Million)
Figure 15 Genotyping Market: Geographical Snapshot
Figure 16 Technological Advancements and Decreasing Prices of DNA Sequencing are Driving Market Growth
Figure 17 Reagents & Kits Commanded the Largest Share of the Market in 2017
Figure 18 The US Accounted for the Largest Share of the Genotyping Market in 2017
Figure 19 Asia Pacific to Grow at the Highest CAGR in the Forecast Period
Figure 20 Developing Markets to Register Higher Growth During the Forecast Period
Figure 21 Comparative Analysis of Human Whole-Genome Sequencing Cost and Amount of Data Produced Per Genome (2001–2017)
Figure 22 FDA 510(K) Approval Process
Figure 23 Europe: Classification of Genotyping Products
Figure 24 Regulatory Process for Genotyping Products in Japan
Figure 25 India: Regulatory Process for Genotyping Products
Figure 26 Reagents & Kits Segment to Witness the Highest Growth During the Forecast Period (2018–2023)
Figure 27 Sequencers & Amplifiers Segment to Register the Highest Growth in the Genotyping Instruments Market During the Forecast Period
Figure 28 Software Segment to Register the Highest Growth Rate in the Genotyping Bioinformatics Market During the Forecast Period
Figure 29 Sequencing Segment to Witness the Highest Growth During the Forecast Period (2018–2023)
Figure 30 Real-Time PCR Segment Will Continue to Dominate the Market in 2023
Figure 31 NGS Segment to Witness the Highest Growth During the Forecast Period
Figure 32 AFLP Segment to Witness the Highest Growth During the Forecast Period
Figure 33 Pharmacogenomics Segment to Witness the Highest Growth During the Forecast Period
Figure 34 Pharmaceutical & Biopharmaceutical Companies to Witness the Highest Growth Rate in the Genotyping Market During the Forecast Period
Figure 35 Geographical Snapshot: Markets in Asia Pacific are Emerging Hotspots
Figure 36 North America: Genotyping Market Snapshot
Figure 37 Europe: Genotyping Market Snapshot
Figure 38 APAC: Genotyping Market Snapshot
Figure 39 Key Developments of Major Players Between January 2015 and March 2018
Figure 40 Genotyping Market Share Analysis, By Key Player, 2017
Figure 41 Product Launches, Approvals, & Enhancements Was the Key Growth Strategy Adopted By Major Players Between 2015 & 2018
Figure 42 Illumina, Inc.: Company Snapshot (2017)
Figure 43 Thermo Fisher Scientific, Inc.: Company Snapshot (2017)
Figure 44 F. Hoffmann-La Roche Ltd.: Company Snapshot (2017)
Figure 45 Qiagen N.V.: Company Snapshot (2017)
Figure 46 Danaher Corporation: Company Snapshot (2017)
Figure 47 Agilent Technologies: Company Snapshot (2017)
Figure 48 Fluidigm Corporation: Company Snapshot (2017)
Figure 49 GE Healthcare: Company Snapshot (2017)
Figure 50 Perkinelmer, Inc.: Company Snapshot (2017)
Figure 51 Bio-Rad Laboratories: Company Snapshot (2017)
Figure 52 Eurofins Scientific: Company Snapshot (2017)
Figure 53 Pacific Biosciences of California, Inc.: Company Snapshot (2017)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 3397
Published ON
Nov, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Genotyping Assay Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved